Nobilis Health Announces Results of 2016 Annual General Meeting of Shareholders
/EINPresswire.com/ -- HOUSTON, TX -- (Marketwired) -- 06/28/16 -- Nobilis Health Corp. ("Nobilis" or the "Company") (NYSE MKT: HLTH) (TSX: NHC) today announced the director election results from its 2016 annual general meeting of shareholders held on June 28, 2016 (the "Meeting"). A ballot was conducted with respect to the election of the directors to hold office until the next annual meeting of shareholders. According to the proxies received and ballots cast, the following directors were elected to hold office until the next annual meeting of shareholders or until their successors are elected or appointed, unless such office is earlier vacated in accordance with the articles of the Company:
---------------------------------------------------------------------------- # Votes % Votes Nominee # Votes For % Votes For Withheld Withheld ---------------------------------------------------------------------------- Steve Ozonian 31,145,887 89.50 3,654,053 10.50 ---------------------------------------------------------------------------- Richard Ganley 10,558,181 30.34 24,241,759 69.66 ---------------------------------------------------------------------------- Jennifer Hauser 8,582,262 24.66 26,217,678 75.34 ---------------------------------------------------------------------------- Dr. Donald Kramer 34,712,009 99.75 87,931 0.25 ---------------------------------------------------------------------------- Tom Foster 34,596,202 99.41 203,738 0.59 ---------------------------------------------------------------------------- Peter Horan 34,720,109 99.77 79,831 0.23 ---------------------------------------------------------------------------- Michael C. Nichols 34,720,409 99.77 79,531 0.23 ----------------------------------------------------------------------------
As Mr. Ganley and Ms. Hauser did not receive the requisite majority of votes "FOR" their election as directors at the Meeting, per the Company's Majority Voting Policy, Mr. Ganley and Ms. Hauser have tendered their resignations as directors of the Company. The board of directors of the Company (the "Board"), pursuant to the terms of the Company's Majority Voting Policy, reviewed, considered and accepted such resignations.
The Board wishes to thank Mr. Ganley and Ms. Hauser for their service as directors.
Shareholders also voted in favor of setting the number of directors at seven for the ensuing year, ratifying and approving the Company's Advance Notice Policy and appointing Crowe Horwath LLP as auditor of the Company.
For further information regarding the voting results for matters considered and approved by the shareholders at the Meeting, please see the Company's report of voting results that has been filed on SEDAR at www.sedar.com and the Company's Current Report on Form 8-K that has been filed on EDGAR at www.sec.gov.
About Nobilis Health Corp.
Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with thirty-three additional facilities throughout the country, and markets six independent brands. Deploying a unique patient acquisition strategy driven by direct-to-consumer marketing, Nobilis is focused on a specified set of procedures that are performed at our centers by local physicians.
Cautionary Statement Regarding Forward-Looking Information
This news release contains forward-looking statements (within the meaning of applicable securities laws) and financial outlooks relating to the business of the Company and the environment in which it operates. Forward-looking statements are identified by words such as "believe", "anticipate", "expect", "intend", "plan", "will", "may" and other similar expressions. Some of the forward-looking statements relate to management changes. This risk, and other risks and uncertainties, may cause results to differ materially from those set forth in the forward-looking statements. Additional risks and uncertainties are further discussed in the Company's regulatory filings available on the Company's web site at www.NobilisHealth.com, www.Sedar.com, and www.sec.gov in the risk factors described in the Company's Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. Other than as required by law, the Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.
Contact Information:
Kolin Ozonian
Vice President, Corporate Development
kozonian@nobilishealth.com
713-355-8614
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.